APA

Fritsch K., Kasenda B., Schorb E., Hau P., Bloehdorn J., Möhle R., Löw S., Binder M., Atta J., Keller U., Wolf H., Krause S. W., Heß G., Naumann R., Sasse S., Hirt C., Lamprecht M., Martens U., Morgner A., Panse J., Frickhofen N., Röth A., Hader C., Deckert M., Fricker H., Ihorst G., Finke J. & Illerhaus G. (20171009). High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). : Leukemia.

Chicago

Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Möhle R, Löw S, Binder M, Atta J, Keller U, Wolf H-H, Krause S W, Heß G, Naumann R, Sasse S, Hirt C, Lamprecht M, Martens U, Morgner A, Panse J, Frickhofen N, Röth A, Hader C, Deckert M, Fricker H, Ihorst G, Finke J and Illerhaus G. 20171009. High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). : Leukemia.

Harvard

Fritsch K., Kasenda B., Schorb E., Hau P., Bloehdorn J., Möhle R., Löw S., Binder M., Atta J., Keller U., Wolf H., Krause S. W., Heß G., Naumann R., Sasse S., Hirt C., Lamprecht M., Martens U., Morgner A., Panse J., Frickhofen N., Röth A., Hader C., Deckert M., Fricker H., Ihorst G., Finke J. and Illerhaus G. (20171009). High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). : Leukemia.

MLA

Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Möhle R, Löw S, Binder M, Atta J, Keller U, Wolf H-H, Krause S W, Heß G, Naumann R, Sasse S, Hirt C, Lamprecht M, Martens U, Morgner A, Panse J, Frickhofen N, Röth A, Hader C, Deckert M, Fricker H, Ihorst G, Finke J and Illerhaus G. High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). : Leukemia. 20171009.